多电解质溶液与生理盐水作为儿童脓毒性休克复苏推注液的比较:一项多中心随机临床试验
该平行组、盲法多中心试验纳入印度4个三级中心PICU中≤15岁的脓毒性休克患儿,随机接受MES(PlasmaLyte A,n=351)或0.9%生理盐水(n=357)推注复苏。主要终点为液体复苏后7天内新发和/或进展性急性肾损伤(AKI),MES组21% vs 生理盐水组33%,RR 0.62(95%CI 0.49-0.80;p<0.001)。MES组在24、48、72小时高氯血症比例更低;ICU死亡率两组无差异(MES 33% vs 生理盐水34%),输液相关不良事件(发热、血栓性静脉炎、液体过负荷)两组无差异。
要点
- 儿童脓毒性休克用MES推注复苏,7天内新发和/或进展性AKI为21%,生理盐水组为33%,RR 0.62(95%CI 0.49-0.80;p<0.001)。
- MES组在24、48、72小时高氯血症比例均低于生理盐水组。
- ICU死亡率MES组33% vs 生理盐水组34%,两组无差异。
- 输液相关不良事件如发热、血栓性静脉炎、液体过负荷两组无差异。
- 研究纳入印度4个三级中心PICU的≤15岁脓毒性休克患儿,中位年龄5岁(IQR 1.3-9),女孩302例(43%)。
适用人群与场景
- 印度4个三级中心PICU中≤15岁的脓毒性休克患儿,中位年龄5岁(IQR 1.3-9),女孩302例(43%)。
处置流程与药物剂量
- 在识别休克时随机给予MES(PlasmaLyte A)或0.9%生理盐水推注液体复苏,所有患儿按标准方案管理并监测至出院/死亡。
- MES组n=351,0.9%生理盐水组n=357,于最初7天内进行推注液体复苏。
研究设计与关键结果
- 平行组、盲法多中心试验,2017至2020年印度4个三级中心PICU,纳入≤15岁脓毒性休克患儿,MES组n=351 vs 0.9%生理盐水组n=357。
- 主要终点为液体复苏后7天内新发和/或进展性AKI:MES组21% vs 生理盐水组33%,RR 0.62(95%CI 0.49-0.80;p<0.001)。
- 高氯血症比例在24、48、72小时MES组均低于生理盐水组。
- ICU死亡率MES组33% vs 生理盐水组34%,两组无差异。
- 输液相关不良事件如发热、血栓性静脉炎、液体过负荷两组无差异。
证据类型、等级与局限
- 证据类型:平行组、盲法多中心随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在脓毒性休克患儿中,与0.9%生理盐水相比,使用MES(平衡晶体液)进行液体复苏可使住院最初7天内新发和/或进展性AKI发生率显著降低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine if initial fluid resuscitation with balanced crystalloid (e.g., multiple electrolytes solution [MES]) or 0.9% saline adversely affects kidney function in children with septic shock.
DESIGN: Parallel-group, blinded multicenter trial.
SETTING: PICUs of four tertiary care centers in India from 2017 to 2020.
PATIENTS: Children up to 15 years of age with septic shock.
METHODS: Children were randomized to receive fluid boluses of either MES (PlasmaLyte A) or 0.9% saline at the time of identification of shock. All children were managed as per standard protocols and monitored until discharge/death. The primary outcome was new and/or progressive acute kidney injury (AKI), at any time within the first 7 days of fluid resuscitation. Key secondary outcomes included hyperchloremia, any adverse event (AE), at 24, 48, and 72 hours, and all-cause ICU mortality.
INTERVENTIONS: MES solution ( n = 351) versus 0.9% saline ( n = 357) for bolus fluid resuscitation during the first 7 days.
MEASUREMENTS AND MAIN RESULTS: The median age was 5 years (interquartile range, 1.3-9); 302 (43%) were girls. The relative risk (RR) for meeting the criteria for new and/or progressive AKI was 0.62 (95% CI, 0.49-0.80; p < 0.001), favoring the MES (21%) versus the saline (33%) group. The proportions of children with hyperchloremia were lower in the MES versus the saline group at 24, 48, and 72 hours. There was no difference in the ICU mortality (33% in the MES vs 34% in the saline group). There was no difference with regard to infusion-related AEs such as fever, thrombophlebitis, or fluid overload between the groups.
CONCLUSIONS: Among children presenting with septic shock, fluid resuscitation with MES (balanced crystalloid) as compared with 0.9% saline resulted in a significantly lower incidence of new and/or progressive AKI during the first 7 days of hospitalization.
参考来源
- Sankar J, Muralidharan J, Lalitha AV, et al. Multiple Electrolytes Solution Versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial. Crit Care Med. 2023. PMID: 37294145. doi:10.1097/CCM.0000000000005952
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。